2/27/26 16:01 | 2/25/26 | CRBU | Health | BioPrd | Biological Products, (No Diag | Kelly Timothy P | CA | O | CTO | S | -12 | 1.93 | 0 | -6 | -8 | 73 | D | | | | | | | | | | | | | | |
2/24/26 20:54 | 2/24/26 | CRBU | Health | BioPrd | Biological Products, (No Diag | Kelly Timothy P | CA | O | CTO | S.d | -6 | 1.96 | 0 | -3 | -4 | 79 | D | | | | | | | | | | | | | | |
2/24/26 20:54 | 2/24/26 | CRBU | Health | BioPrd | Biological Products, (No Diag | McClung Barbara G | CA | O | GC | S.d | -14 | 1.96 | 0 | -7 | -1 | 482 | D | | | | | | | | | | | | | | |
2/24/26 20:54 | 2/24/26 | CRBU | Health | BioPrd | Biological Products, (No Diag | Khan Ruhi Ahmad | CA | O | Chief Bu | S.d | -14 | 1.96 | 0 | -7 | -6 | 105 | D | | | | | | | | | | | | | | |
2/24/26 20:53 | 2/24/26 | CRBU | Health | BioPrd | Biological Products, (No Diag | Albertson Tina M. | CA | O | Chief Me | S.d | -2 | 1.96 | 0 | -1 | -2 | 69 | D | | | | | | | | | | | | | | |
3/17/25 08:01 | 3/14/25 | CRBU | Health | BioPrd | Biological Products, (No Diag | Haurwitz Rachel E. | CA | DO | P,CEO | P | 20 | 1.02 | 0 | 20 | 1 | 3,665 | I | | | | | | | | | | | | | | |
2/21/25 20:19 | 2/21/25 | CRBU | Health | BioPrd | Biological Products, (No Diag | McClung Barbara G | CA | O | GC | S.d | -5 | 1.35 | 0 | -4 | -1 | 444 | D | | | | | | | | | | | | | | |
2/21/25 20:19 | 2/21/25 | CRBU | Health | BioPrd | Biological Products, (No Diag | Khan Ruhi Ahmad | CA | O | Chief Bu | S.d | -5 | 1.35 | 0 | -4 | -5 | 67 | D | | | | | | | | | | | | | | |
2/21/25 20:18 | 2/21/25 | CRBU | Health | BioPrd | Biological Products, (No Diag | Kanner Steven | CA | O | Chief Sc | S.d | -5 | 1.35 | 0 | -4 | -1 | 432 | D | | | | | | | | | | | | | | |
1/30/25 16:02 | 1/29/25 | CRBU | Health | BioPrd | Biological Products, (No Diag | Ryali Sriram | CA | O | CFO | P | 25 | 1.42 | 0 | 17 | New | 17 | D | | | | | | | | | | | | | | |
2/8/24 17:06 | 2/6/24 | CRBU | Health | BioPrd | Biological Products, (No Diag | Kanner Steven | CA | O | Chief Sc | M.d | 82 | 2.69 | 0 | 31 | 9 | 354 | D | | | | | | | | | | | | | | |